Literature DB >> 36268124

Virtual Special Issue: Epigenetics 2022.

Courtney C Aldrich, Félix Calderón, Stuart J Conway, Chuan He, Jacob M Hooker, Donna M Huryn, Craig W Lindsley, Dennis C Liotta, Christa E Müller.   

Abstract

Entities:  

Year:  2022        PMID： 36268124      PMCID： PMC9578134          DOI： 10.1021/acsptsci.2c00169

Source DB:  PubMed          Journal:  ACS Pharmacol Transl Sci        ISSN： 2575-9108


× No keyword cloud information.
  76 in total

1.  Epidrugs in Amyotrophic Lateral Sclerosis/Frontotemporal Dementia: Contextualizing a Role for Histone Kinase Inhibition in Neurodegenerative Disease.

Authors:  Samantha N Cobos; Mariana P Torrente
Journal:  ACS Pharmacol Transl Sci       Date:  2022-01-21

Review 2.  Histone Deacetylases 1 and 2 in Memory Function.

Authors:  Ping-Chieh Pao; Li-Huei Tsai
Journal:  ACS Chem Neurosci       Date:  2022-03-09       Impact factor: 4.418

3.  Diverse, Potent, and Efficacious Inhibitors That Target the EED Subunit of the Polycomb Repressive Complex 2 Methyltransferase.

Authors:  Sharan K Bagal; Clare Gregson; Daniel H O' Donovan; Kurt G Pike; Andrew Bloecher; Peter Barton; Alexandra Borodovsky; Erin Code; Shaun M Fillery; Jessie Hao-Ru Hsu; Sameer P Kawatkar; Chengzhi Li; David Longmire; Youfeng Nai; Samuel C Nash; Andrew Pike; James Robinson; Jon A Read; Phillip B Rawlins; Minhui Shen; Jia Tang; Peng Wang; Haley Woods; Beth Williamson
Journal:  J Med Chem       Date:  2021-11-22       Impact factor: 7.446

Review 4.  From Hit Seeking to Magic Bullets: The Successful Union of Epigenetic and Fragment Based Drug Discovery (EPIDD + FBDD).

Authors:  Miguel M Vaidergorn; Flavio da Silva Emery; A Ganesan
Journal:  J Med Chem       Date:  2021-09-30       Impact factor: 7.446

5.  Novel Bromodomain Inhibitors for Treating Cancer, Fibrosis, and Inflammatory Disorders.

Authors:  Ram W Sabnis
Journal:  ACS Med Chem Lett       Date:  2021-06-29       Impact factor: 4.632

6.  Determination of Slow-Binding HDAC Inhibitor Potency and Subclass Selectivity.

Authors:  Carlos Moreno-Yruela; Christian A Olsen
Journal:  ACS Med Chem Lett       Date:  2022-03-16       Impact factor: 4.632

7.  A Structure-based Design Approach for Generating High Affinity BRD4 D1-Selective Chemical Probes.

Authors:  Huarui Cui; Anand Divakaran; Zachariah J Hoell; Mikael O Ellingson; Cole R Scholtz; Huda Zahid; Jorden A Johnson; Elizabeth C Griffith; Clifford T Gee; Amani L Lee; Shalil Khanal; Ke Shi; Hideki Aihara; Vijay H Shah; Richard E Lee; Daniel A Harki; William C K Pomerantz
Journal:  J Med Chem       Date:  2022-01-10       Impact factor: 8.039

Review 8.  Exploring Methods of Targeting Histone Methyltransferases and Their Applications in Cancer Therapeutics.

Authors:  Michelle Y Wang; Priscilla Liow; Maria I Tarazona Guzman; Jun Qi
Journal:  ACS Chem Biol       Date:  2022-04-01       Impact factor: 4.634

9.  Identification of Potent and Selective Inhibitors of Fat Mass Obesity-Associated Protein Using a Fragment-Merging Approach.

Authors:  Muthuraj Prakash; Yukihiro Itoh; Yoshie Fujiwara; Yukari Takahashi; Yuri Takada; Paolo Mellini; Elghareeb E Elboray; Mitsuhiro Terao; Yasunobu Yamashita; Chika Yamamoto; Takao Yamaguchi; Masayuki Kotoku; Yuki Kitao; Ritesh Singh; Rohini Roy; Satoshi Obika; Makoto Oba; Dan Ohtan Wang; Takayoshi Suzuki
Journal:  J Med Chem       Date:  2021-11-03       Impact factor: 7.446

10.  Novel Bromodomain BRD4 Inhibitors for Treating Cancer.

Authors:  Ram W Sabnis
Journal:  ACS Med Chem Lett       Date:  2021-05-25       Impact factor: 4.632
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.